Anti-TrkA antibodies, derivatives and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9365654
APP PUB NO 20130336964A1
SERIAL NO

13894489

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognize and bind an epitope comprised in the TrkA amino acid sequence, medical uses thereof and a pharmaceutical composition comprising at least one of the above antibody, recombinant or synthetic antigen-binding fragments thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROTTAPHARM BIOTECH S R L20900 MONZA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caselli, Gianfranco Milan, IT 32 88
Rovati, Lucio Claudio Monza, IT 51 122
Ugolini, Gabriele Trieste, IT 6 236
Visintin, Michela Trieste, IT 8 132

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00